The POI Industry Advisory Board (IAB) consists of representatives from each of our industry partners and provides the following supports to our strategic direction;
- Provides guidance to the POI Governance Committee and Executive Committee on matters relating to industry involvement in POI as well as industry trends which may inform POI’s strategic direction.
- Advises and supports POI in terms of developing and expanding mutually beneficial relationships with the industry sector.
- Identification of funding opportunities which may support POI’s growth as a consortium, and support the operations team in the pursuit of obtaining such funds.
- Promoting POI as an innovative research programme for Ireland.
Current and past IAB board members
Mr. Tommy Bracken (Hexagon Consulting, CRC-UCD and Chairperson, POI IAB)
Dr. Claus Bendtsen (AstraZeneca)
Dr. Steven Griffin (Cell Stress Discoveries)
Dr. David Kavanagh (Genuity Science)
Dr. Remco Loos (Celgene)
Dr. Helen McCarty (Phion Therapeutics)
Mr. Des O’Leary (OncoMark)
Mr. Padraig Somers (Helsinn)